News Center
Beijing Lunarsun Pharma is excited to announce that Tigecycline for Injection was approved for production on September 14, 2024.
Approval Number: H20244853
We look forward to discussing potential partnerships with interested pharmaceutical manufacturers.
Copyright(C)2024,Beijing Lunarsun Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle 31fabu Copyright Notice